News

SOFI delivers robust Q2 growth, record member and loan gains, and raises its 2026 revenue outlook despite Technology Platform pressure.

CL's Q2 earnings beat as organic sales, productivity and margin gains offset higher brand investment, while Latin America led regional growth.

GE Aerospace stock rose on Friday, capping a week of gains that left it squarely within a buy zone. Shares rose 1.5% as they rebounded from key technical support. Like most aerospace stocks, GE Aerospace has had a year of ups and downs that has nonetheless yielded gains thus far.

The e-commerce service provider has a lot to prove.

(Updates with latest market prices and developments.) US benchmark equity indexes were higher int

Analysts expect 80% revenue growth this quarter.

PBF's Q2 earnings beat estimates as stronger refining margins, higher throughput and the Martinez restart fuel a sharp profit rebound.

FSLR tops Q2 earnings estimates as gross margin expands, but revenues slip year over year while it maintains its full-year 2026 outlook.

ASE Technology Holding's Q2 earnings beat estimates as AI-driven LEAP and ATM demand boosts revenues, margins and the full-year ATM outlook.

Ross Stores (ROST) is in focus after its May 21, 2026 earnings call, where management reported a 17% comparable store sales gain and raised full year guidance, followed by a 15.8% stock move. See our latest analysis for Ross Stores. At a US$252.57 share price, Ross Stores has shown firm momentum, with a 30 day share price return of 19.19% and a 1 year total shareholder return of 86.02%. This suggests investors are reassessing its growth and risk profile after strong earnings updates and...

In the past few days, AXT, Inc. reported sharply higher second-quarter 2026 sales of US$47.59 million and net income of US$11.13 million, and disclosed a long-term indium phosphide supply and capacity-reservation agreement with Lumentum Operations, LLC backed by up to US$87,500,000 in deposits applied as shipment credits. Alongside these results, AXT moved to expand board expertise, lowered its shareholder meeting quorum threshold, and secured multi‑year indium phosphide commitments that tie...

BlackRock clients bought $273 million in Bitcoin in two days while the average US spot ETF buyer sits 22% underwater.

Taiwan Semiconductor just posted one of the strongest earnings reports in chip-stock history, yet the stock sits 15% below its all-time high. Three specific catalysts could send it to a price Wall Street has not fully priced in yet.

GDDY tops Q2 earnings and revenue estimates as growth across both segments, rising ARPU, and accelerating Airo adoption support results and guidance.

RDDT tops Q2 earnings and revenue estimates as ad demand, pricing and user growth fuel monetization, with Q3 guidance pointing to continued momentum.

Wall Street offered mixed views on Apple’s outlook after earnings, while Stocktwits retail traders largely shrugged off the selloff and stayed bullish.

GLW's AI optics growth, stronger cash flow and rising estimates support upside, but a premium valuation leaves little room for execution misses.

IBM's 2026 pullback improves its price, but modest growth, leverage and a still-full valuation keep the stock from looking clearly cheap.

DXCM's Q2 earnings and revenues beat estimates as global demand, broader access and margin expansion fuel stronger 2026 guidance.

LPLA's Q2 results benefit from strong revenue and advisory asset growth while boosting its buyback authorization. Yet, higher expenses partly offset the gains.

IR beats Q2 earnings and revenue estimates, raises its 2026 sales outlook and reports stronger orders, cash flow and M&A momentum.

SanDisk has taken investors on a wild ride in recent months. For instance, SanDisk (SNDK) stock is up roughly 2,240% over the past 12 months, a return that turned a sleepy chipmaker into one of the most talked-about stocks on Wall Street. Then came the drop. The chip stock has fallen 45% from its ...

Amazon jumped almost 15% while Apple fell 9%. Here's what split the two tech giants and left the major indexes stuck in the middle.

Novo Nordisk and Eli Lilly compete in the same blockbuster drug class, yet their 2026 earnings tell dramatically different stories about which company holds the upper hand heading into a pivotal summer of reports and pricing resets.

CBOE's Q2 earnings beat estimates. Record Options revenues, broad-based growth and stronger margins drove a raised 2026 revenue outlook.

Prediction markets are hot right now, and that could signal big things ahead for Robinhood stock.

dLocal stands out over Priority with faster payment growth, a broader emerging-market network and stronger cash resources despite margin risks.

Amgen heads into Q2 earnings with a history of beats as investors watch key drug sales trends and seek updates on its MariTide obesity candidate.

AbbVie tops Q2 earnings and revenue estimates on strong immunology drug sales, but a lower 2026 EPS outlook tied to the Apogee deal weighs on shares.

(Bloomberg) -- Short sellers have piled into SpaceX at a rapid pace ahead of two major milestones next week: the company’s first earnings report as a public company and the release of hundreds of millions of locked-up shares.Most Read from BloombergSingapore's Gated Island for the Rich Is Marred by Decayed HomesAnthropic AI Models Hacked Three Organizations During TestsMicrosoft’s $450 Billion Jump Is Biggest in Stock Market HistoryChip Stocks Post Biggest Advance Since April 2025: Markets WrapM